Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / RET

RET

Basics

Aliases:
This biomarker is also known as:
  • RET transforming sequence,
  • ret proto-oncogene,
  • RET51,
  • CDHR16,
  • MEN2A,
  • EC 2.7.10.1,
  • receptor tyrosine kinase,
  • Proto-oncogene c-Ret,
  • RET-ELE1,
  • CDHF12,
  • Cadherin family member 12,
  • cadherin-related family member 16,
  • PTC,
  • HSCR1,
  • multiple endocrine neoplasia and medullary thyroid carcinoma 1,
  • MTC1,
  • MEN2B,
  • proto-oncogene tyrosine-protein kinase receptor Ret,
  • proto-oncogene c-Ret,
  • Hirschsprung disease 1,
  • cadherin family member 12,
  • hydroxyaryl-protein kinase,
  • ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease),

View in BioMuta

Description…

ret proto-oncogene

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: RET

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.